Oct 23, 2025 06:03AM
Oct 23, 2025 06:01AM
Sep 30, 2025 07:01AM
Sep 30, 2025 07:00AM
Sep 10, 2025 06:00AM
Apr 15, 2025 09:02AM
Apr 15, 2025 09:00AM NLS Pharmaceutics Announces Positive Results from Study KO-943 Demonstrating Mazindol Reduces Fentanyl-Induced Reward in Animal Models
Jan 28, 2025 07:32AM
Jan 28, 2025 07:30AM
Dec 1, 2023 07:30AM
Jul 3, 2023 07:02AM
Jul 3, 2023 07:00AM
May 8, 2023 08:32AM
May 8, 2023 08:30AM NLS Pharmaceutics Appoints Keith Harrison Dewedoff as Interim Chief Financial Officer
Jan 30, 2023 08:30AM
Jan 23, 2023 08:33AM
Jan 23, 2023 08:30AM
Dec 22, 2022 08:33AM
Dec 22, 2022 08:30AM
Dec 14, 2022 08:30AM
Dec 7, 2022 08:28AM NLS Pharmaceutics (NLSP) Announces Receipt of Nasdaq Minimum Bid Price Notification
Dec 7, 2022 08:25AM
Dec 1, 2022 08:00AM
Nov 23, 2022 08:32AM
Nov 23, 2022 08:30AM
Sep 27, 2022 08:04AM
Sep 27, 2022 08:00AM
Aug 19, 2021 07:53AM NLS Pharmaceutics (NLSP) Announces Notice of Allowance for U.S. Patent Application Covering its Proprietary Mazindol Formulation
Aug 19, 2021 07:52AM
Jul 15, 2021 08:26AM
Jul 15, 2021 08:15AM

322,950 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All